1-3 of 3
Janet Sim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

Amy Chen, Ons Harrabi, Abraham P Fong, MDPhD, Katherine L. Ruffner, MD, Alison J. Forgie, PhD, Janet Sim, PhD, Sophia S Randolph, MDPhD, Hong Wan, PhD, Jaume Pons, PhD, Tracy C Kuo, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-137112
Published: 2020
Journal Articles

ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models

Steven E Kauder, PhD, Tracy C Kuo, PhD, Amy Chen, Ons Harrabi, Sony S Rocha, Laura Doyle, Sangeetha Bollini, Bora Han, PhD, Emma Ruth B Sangalang, Janet Sim, PhD, Sophia Randolph, MDPhD, Jaume Pons, PhD, Hong I Wan, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 112.
https://doi.org/10.1182/blood.V130.Suppl_1.112.112
Published: 2017
Journal Articles

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation

Jing Lu, Tatiana Zavorotinskaya, Yumin Dai, Xiao-Hong Niu, Joseph Castillo, Janet Sim, Jianjun Yu, Yingyun Wang, John L. Langowski, Jocelyn Holash, Kevin Shannon, Pablo D. Garcia
Journal: Blood
Blood (2013) 122 (9): 1610–1620.
https://doi.org/10.1182/blood-2013-01-481457
Published: 2013
Includes: Supplemental data